Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 39 min 42 sec ago

Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune

Mon, 08/10/2015 - 13:56
Agreement Includes Clinical-Stage INO-3112 HPV Cancer Vaccine and Preclinical Collaboration to Develop Additional Cancer Vaccine Candidates Inovio Schedules Conference Call for 8:30am ET Today; Go to and Click on "Webcast" Tab PL...
Biopharmaceuticals, Licensing
Inovio Pharmaceuticals, MedImmune, AstraZeneca, INO-3112, HPV

Timothy E. Morris Joins PAION Inc. As A Non Executive Director

Fri, 08/07/2015 - 15:18
Mr. Timothy E. Morris will advise PAION Inc. in building up and financing of the growing U.S. activities and in preparing for the upcoming commercialisation of Remimazolam MAHWAH, N.J., Aug. 7, 2015 -- (Healthcare Sales & Marketing Network) -- PAION, I...
Biopharmaceuticals, Personnel
PAION Inc, Remimazolam

JenaValve Receives $26.5 Million Financing

Fri, 08/07/2015 - 15:10
Proceeds to Enable Clinical Studies and Commercial Development of Innovative TAVR Systems Targeting Broad Patient Population IRVINE, Calif.--(Healthcare Sales & Marketing Network)--JenaValve Technology, Inc., a developer, manufacturer and marketer of ne...
Devices, Interventional Cardiology, Venture Capital
JenaValve Technology, transcatheter aortic valve, aortic valve

Flowonix Medical Inc. Announces FDA Approval of New Product

Fri, 08/07/2015 - 15:03
MOUNT OLIVE, N.J., Aug. 7, 2015 -- (Healthcare Sales & Marketing Network) -- Flowonix Medical, Inc., announced today that its newest product, the Patient Therapy Controller (PTC™), has been approved for market release. The PTC interfaces with the company'...
Devices, Drug Delivery, FDA
Flowonix Medical, Patient Therapy Controller

NICE Recommends Once-daily Lixiana(R) (Edoxaban) for Preventing Stroke and Systemic Embolism in People with Non-valvular Atrial Fibrillation

Fri, 08/07/2015 - 13:40
NICE Final Appraisal Determination recommends that edoxaban is a cost effective use of NHS resources GERRARDS CROSS, England, August 7, 2015 -- (Healthcare Sales & Marketing Network) -- The National Institute for Health and Care Excellence (NICE) has r...
Biopharmaceuticals, Cardiology, Regulatory
Daiichi Sankyo, Lixiana, edoxaban, stroke, atrial fibrillation, DVT

Stryker Receives FDA Clearance for Mako Total Knee Application

Thu, 08/06/2015 - 22:03
Kalamazoo, Michigan - August 6, 2015 - Stryker Orthopaedics, a division of Stryker Corporation (SYK), today announced that its 510(k) submission for the Mako total knee application has received market clearance by the U.S. Food and Drug Administration. ...
Devices, Orthopaedic, FDA
Stryker, Mako, Triathlon, Total Knee

Merrimack Pharmaceuticals Names Dr. Yasir Al-Wakeel as Chief Financial Officer and Head of Corporate Development

Thu, 08/06/2015 - 16:00
CAMBRIDGE, Mass., Aug. 6, 2015 -- (Healthcare Sales & Marketing Network) -- Merrimack Pharmaceuticals, Inc. (MACK) today announced that Yasir Al-Wakeel, MA, BM BCh will be appointed Chief Financial Officer and head of Corporate Development on August 11, 2...
Biopharmaceuticals, Drug Delivery, Oncology, Personnel
Merrimack Pharmaceuticals, irinotecan, liposome, pancreatic cancer

Virtual Incision Closes $11 Million Equity Financing for First-of-its-Kind Miniaturized Robot for General Surgery

Thu, 08/06/2015 - 15:56
Funding to be Used for First-In-Human Feasibility Trial for Colon Resection Procedures PLEASANTON, Calif. & LINCOLN, Neb.--(Healthcare Sales & Marketing Network)--Virtual Incision Corporation, a company developing advanced robotically assisted surgical ...
Devices, Surgery, Venture Capital
Virtual Incision, robotic surgery

Elekta Receives US 510(k) Clearance for Its Latest Generation Intracranial Radiosurgery System, Leksell Gamma Knife Icon

Wed, 08/05/2015 - 15:18
ATLANTA, August 5, 2015 -- (Healthcare Sales & Marketing Network) --Elekta's Leksell Gamma Knife® Icon™ radiosurgery system has received 510(k) clearance from the US Food and Drug Administration, enabling US health care providers to offer this advance...
Devices, Neurosurgery, Oncology, FDA
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

St. Jude Medical Appoints David Dvorak to Its Board of Directors

Wed, 08/05/2015 - 15:14
ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced the appointment of David C. Dvorak — President and Chief Executive Officer of Zimmer Biomet — to its Board of Directors,...
Devices, Cardiology, Personnel
St. Jude Medical

Metacrine Raises $36 Million in Series A Financing

Wed, 08/05/2015 - 15:12
Appoints Neil McDonnell, CEO, Along with Executive Team and Board SAN DIEGO, Aug. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Metacrine, Inc., a biotechnology company focused on targeting metabolic disease through advances in endocrine researc...
Biopharmaceuticals, Venture Capital, Personnel
Metacrine, non-alcoholic steatohepatitis, diabetes

Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer

Wed, 08/05/2015 - 15:08
Dr. Taraporewala Appointed Chief Technology Officer NEW YORK, Aug. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Ohr Pharmaceutical, Inc. (OHRP), an ophthalmology research and development company announced today that Jason S. Slakter, MD, has bee...
Biopharmaceuticals, Ophthalmology, Personnel
Ohr Pharmaceutical, Squalamine

InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer

Wed, 08/05/2015 - 13:22
New Leadership to Advance Cardiovascular Monitoring Company Into Commercialization Phase WEXFORD, PA--(Healthcare Sales & Marketing Network) - InteloMed, Inc., an emerging leader and developer of non-invasive cardiovascular monitoring technology, today ...
Devices, Cardiology, Monitoring, Personnel
InteloMed, CVInsight

Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer

Wed, 08/05/2015 - 13:15
SAN DIEGO and GAITHERSBURG, Md., Aug. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Mirati Therapeutics, Inc. ("Mirati") (MRTX), an oncology company focusing on genetic and epigenetic drivers of cancer, and MedImmune, the global biologics...
Biopharmaceuticals, Oncology
Mirati Therapeutics, MedImmune, AstraZeneca, mocetinostat

Hetero Announces the Launch of Biosimilar Rituximab (MABALL(TM)) in India

Wed, 08/05/2015 - 13:05
HYDERABAD, India, August 5, 2015 -- (Healthcare Sales & Marketing Network) --Hetero Group, one of India's leading generic pharmaceutical companies and one of the world's largest global producer of anti-retroviral drugs for HIV/AIDS treatment, today announ...
Biopharmaceuticals, Generics, Oncology, Product Launch
Hetero Group, biosimilar, Rituximab, MABALL, Rituxan, Genentech, Roche Group

Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer

Tue, 08/04/2015 - 17:50
MORAGA, Calif., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced today that the company h...
Biopharmaceuticals, Drug Delivery, Personnel
Trigemina , headache, migraine, intranasal oxytocin, oxytocin

Healeon Medical Names Dr. Robert Alexander as Chief Scientific Officer

Tue, 08/04/2015 - 16:17
Dr. Alexander Brings Years of Research and Clinical-Based Experience To The Healeon Team NEWBURY PARK, Calif., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Healeon Medical, Inc. is proud to announce the addition of Dr. Robert Alexander as ...
Regenerative Medicine, Personnel
Healeon Medical, CENTRIcyte 1000

Mevion Medical Systems Forming Joint Venture in China and Secures up to $200MM in Financing

Tue, 08/04/2015 - 16:13
Completion of financing with leading investors from China will support Mevion’s global commercialization strategy LITTLETON, Mass.--(Healthcare Sales & Marketing Network)--Mevion Medical Systems, the leading provider of advanced proton therapy systems, ...
Devices, Oncology, Venture Capital
Mevion Medical Systems, proton therapy, radiotherapy

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms

Tue, 08/04/2015 - 16:08
PHOENIX, AZ--(Healthcare Sales & Marketing Network) - Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its pharmac...
Biopharmaceuticals, Neurology, FDA
Insys Therapeutics, cannabidiol, Infantile Spasm

Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio

Tue, 08/04/2015 - 16:04
MARLBOROUGH, Mass., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) has closed on the previously announced agreement with Endo International plc (ENDP) (ENL.TO) to purchase American Medical Systems' (AMS) Men'...
Devices, Urology, Acquisitions
Boston Scientific, American Medical Systems

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong